Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul;21(7):1147-54.
doi: 10.1016/j.drudis.2016.05.004. Epub 2016 May 11.

Current Therapies for Premature Ejaculation

Affiliations
Review

Current Therapies for Premature Ejaculation

Serap Gur et al. Drug Discov Today. .

Abstract

Premature ejaculation (PE) subjectively affects 20-30% of men globally. Until recently, understanding of PE was hampered by the absence of a widely accepted definition, paucity of evidence-based clinical studies, and the absence of an appropriate animal model. Here, we elaborate on the current definition of PE, its pathogenesis, currently available therapies, and future treatment prospects. Most treatments for PE are 'off-label' and include selective serotonin reuptake inhibitors (SSRIs), topical anesthetics, tramadol, and phosphodiesterase type 5 (PDE5) inhibitors. Such knowledge of the benefit and limitations of each treatment will help to direct future drug design and formulations.

Similar articles

See all similar articles

LinkOut - more resources

Feedback